The stock market has a way of proving the masses wrong. After all the chatter about the new administration’s potentially adverse impact on pharmaceutical stocks and related industries ...

Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

More importantly, there are lots of other types of vaccines that are key growth drivers for some pharmaceutical companies. Here's what you need to know about investing in the top vaccine stocks ...

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends BioMarin Pharmaceutical. The Motley Fool has a disclosure policy.

ARS Pharmaceuticals, Inc.'s stock soared 25% on strong earnings. Learn about neffy's market potential, risks, and future ...

WASHINGTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Shares of biotech company BioMarin Pharmaceutical (NASDAQ ... But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be ...

Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a ...

Explore Tonix Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TNXP. Tonix's TNX-1500 Shows Promise In Preventing Organ Transplant ...

William Blair writes that West Pharmaceutical stock currently trades at 52.8 times the midpoint of the company's 2025 adjusted EPS guidance. "Generally speaking, we expect the stock to track to ...